Clinical Trials on Attention Difficulties in Ireland

Total 52 results

University of Limerick
Irish Research Council

Completed

Evaluation of a School-Based Attention Training Programme for Improving Concentration

Attention Concentration Difficulty

Ireland
National University of Ireland, Maynooth
Irish Research Council; Dublin City University

Completed

Dynamic Difficulty Adjustment in a P300 Speller Task for Attention Training

Attention

Ireland
University College Cork
University of Ulster

Unknown

Attentional Capacity and Clinician Performance (ACCP)

Change in Sustained Attention

Ireland
University of Iceland

Active, not recruiting

Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD)

Attention-deficit Hyperactivity

Iceland
University of Iceland

Completed

Evaluating the Feasibility of FAM-SOTC Intervention for Families of Adolescents With ADHD: Pilot Study

Attention Deficit Hyperactivity Disorder Combined

Iceland
University of Rhode Island
Lehigh University

Completed

Effects of LDX on Functioning of College Students With ADHD

Attention-deficit/Hyperactivity Disorder

United States
Bradley Hospital
National Institute of Mental Health (NIMH)

Unknown

Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls (BBPP)

Healthy | Generalized Anxiety Disorder | Bipolar Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without Hyperactivity

United States
University of Iceland
Stockholm University

Recruiting

Emotion Regulation as a Moderator of Two Different Treatments for Children With ODD

Oppositional Defiant Disorder

Iceland
Rhode Island Hospital
Bradley Hospital; Nancy Lurie Marks Family Foundation

Completed

Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder

ADHD

United States
Rhode Island Hospital
Eli Lilly and Company

Unknown

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Rhode Island Hospital

Completed

The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention Deficit Hyperactivity Disorder

United States
University College Hospital Galway

Completed

Early Post-operative Removal of Urethral Catheter in Patients Undergoing Colorectal Surgery With Epidural Analgesia

Urinary Retention

Ireland
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Columbia University; New York State... and other collaborators

Unknown

Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager (shared care)

ADHD

United States
Shire

Completed

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Cephalon

Completed

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

ADHD | Attention Deficit/Hyperactivity Disorder

United States
Women and Infants Hospital of Rhode Island
American Urogynecologic Society; American Association of Gynecologic Laparoscopists

Active, not recruiting

Optimization of Spontaneous Postoperative Trial of Void Among Women (OPTION)

Voiding Disorders | Urinary Retention Postoperative

United States
Shire

Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Attention-deficit/Hyperactivity Disorder

United States, Canada, Germany, Hungary, Sweden
Eli Lilly and Company

Completed

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Attention-Deficit/Hyperactivity Disorder

Canada
Shire

Completed

Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Sunovion

Completed

Adult Attention Deficit Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents (ADHD LIFE)

Attention Deficit Hyperactivity Disorder

Italy, Spain, France, Belgium, Turkey, Ireland, Mexico, Norway, United Kingdom
Shire

Completed

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

Attention-Deficit/Hyperactivity Disorder

United States
Shire

Completed

Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

United States
Novartis

Completed

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

ADHD, ADD

United States
The Miriam Hospital

Completed

mHealth Intervention Supporting HIV Treatment Adherence and Retention

HIV | Adherence | Retention

United States
Cephalon

Completed

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

Attention Deficit Hyperactivity Disorder

United States
Theravance Biopharma

Completed

A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD | Attention-Deficit/Hyperactivity Disorder

United States
Shire

Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Attention Deficit Hyperactivity Disorder (ADHD)

Spain, Germany, Ukraine, France, Italy, Austria, Belgium, Ireland, Netherlands, Poland, Romania, Sweden, United Kingdom
Shire

Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Attention-deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Open-label Safety Study in Adults With ADHD

Adult Attention Deficit Hyperactivity Disorder

United States
Shire

Completed

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Abbott

Completed

A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA); University of Colorado, Denver

Completed

Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)

ADHD | Substance Abuse

United States
Shire

Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention-deficit/Hyperactivity Disorder

Spain, Belgium, United States, Netherlands, United Kingdom, Italy, Germany, Canada, France, Sweden
Shire

Completed

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Attention-Deficit/Hyperactivity Disorder

United States, Poland, Spain, Canada, Hungary, Belgium, Germany, Italy, Sweden, United Kingdom
Shionogi

Completed

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Purdue Pharma LP

Terminated

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) (RE-DAX)

Attention-Deficit/Hyperactivity Disorder

United States
Sunovion

Completed

Dasotraline Pediatric Extension Study

Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Dasotraline Pediatric ADHD Study

Attention Deficit Hyperactivity Disorder

United States
Shire

Completed

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
Shire

Completed

Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD Specifically With Executive Function Impairment

United States
Shire

Completed

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

Attention-Deficit/Hyperactivity Disorder

United States, Canada
Rhode Island Hospital
Brown University

Unknown

Treatment of Conduct Problems and Depression

Depression | Conduct Disorder | Oppositional Defiant Disorder

United States
Shire

Completed

Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Women and Infants Hospital of Rhode Island

Completed

Treatment for Acute Postoperative Voiding Dysfunction (PTNS)

Urinary Retention

United States
Sunovion

Completed

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Insomnia | Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Long-Term, Open Label Atomoxetine Study

Attention Deficit Hyperactivity Disorder

United States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
Sunovion

Completed

Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia

Insomnia | Attention Deficit Hyperactivity Disorder

United States

Clinical Trials on Attention Difficulties in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations